Related references
Note: Only part of the references are listed.Case series of patients with severe sickle cell disease treated with voxelotor (GBT440) by compassionate access
Gershwin Blyden et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Voxelotor (GBT440) produces interference in measurements of hemoglobin S
Nicola J. Rutherford et al.
CLINICA CHIMICA ACTA (2018)
Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin
Brian Metcalf et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Treating sickle cell disease by targeting HbS polymerization
William A. Eaton et al.
BLOOD (2017)
Share Paper
